Several neuroendocrine studies with the clonidine-growth hormone stimulation test show endogenous depressive patients to have a reduced GH response as compared to neurotic depressives, schizophrenics and controls. The blunted GH response to clonidine seems to be a trait marker or vulnerability factor for mono- and bipolar endogenous depression. It could be explained by a reduced postsynaptic alpha 2-adrenoceptor sensitivity or of structures related to them. The sensitivity of alpha 2-adrenoceptors is influenced by both, the endorphinergic and cholinergic systems. First results supporting this concept are presented and discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000285135 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!